Results 211 to 220 of about 102,210 (307)

Thrombus‐Induced Prosthetic Valve Dysfunction Demonstrating Hypo‐Attenuated Leaflet Thickening: A Case Report

Clinical Case Reports, Volume 14, Issue 9, September 2026.
ABSTRACT Hypo‐attenuated leaflet thickening (HALT) is an important and potentially underrecognized cause of late bioprosthetic valve dysfunction after surgical AVR. Multimodal imaging, including echocardiography and electrocardiogram‐gated computed tomography, is essential for diagnosis, and timely surgical or medical intervention can effectively ...
Takanori Kono, Kazuyoshi Takagi, Yusuke Shintani, Hiroki Mine, Eiki Tayama   +4 more
wiley   +1 more source

Drug-Drug Interactions Between Oral Anticoagulants and Calcineurin Inhibitors in Nephrotic Syndrome for Management of Thromboembolism. [PDF]

Biomedicines
Hirai T, Katayama K.
europepmc   +1 more source

Hydrocephalus and Diffuse Alveolar Hemorrhage as the Initial Manifestation of Systemic Lupus Erythematosus and Antiphospholipid Syndrome: A Case Report

Clinical Case Reports, Volume 14, Issue 9, September 2026.
ABSTRACT Systemic lupus erythematosus (SLE) is an autoimmune disease that can affect many systems, such as the central nervous system (CNS), cardiovascular, musculocutaneous, renal, and respiratory systems, etc. SLE can occur alone or in association with other autoimmune diseases, especially antiphospholipid syndrome (APS).
Ehsan Adib, Narges Gorbanmaleki, Amirreza Eterafi, Sara Jalali Jivan   +3 more
wiley   +1 more source

Anticoagulant Use and Frequency of Vascular Access Thrombosis: A Retrospective Cohort Study. [PDF]

Perm J
Shaheed T, Stram D, Shirazi A, Iwasaki S, Davila C, Zheng S.   +5 more
europepmc   +1 more source

Concomitant Lemierre's Syndrome and Base‐of‐Skull Osteomyelitis Caused by Arcanobacterium haemolyticum, Complicated by Ceftriaxone‐Associated Cholecystitis: A Case Report

Clinical Case Reports, Volume 14, Issue 9, September 2026.
ABSTRACT Lemierre's syndrome and base‐of‐skull osteomyelitis can occur together in immunocompetent adolescents with Arcanobacterium haemolyticum bacteraemia. Prolonged high‐dose ceftriaxone may precipitate symptomatic cholecystitis. Clinicians should consider A.
Angus Lane, Alexandra Stewart
wiley   +1 more source

Impact of Atrial Fibrillation on the Risk of Thrombosis and Bleeding for Patients With Polycythemia Vera and Essential Thrombocytosis in the Real World

American Journal of Hematology, Volume 101, Issue 9, Page 2463-2468, September 2026.
Rodrigo Ortega Perez, Luis Manuel Domínguez Rodríguez, Francisca Ferrer‐Marín, Beatriz Cuevas Ruíz, Clara Martínez Valverde, Patricia Vélez Tenza, María Isabel Mata Vázquez, Adrián Segura Díaz, María Laura Fox, Elvira Mora, Manuel Mateo Pérez Encinas, Mercedes Gasior Kabat, Gonzalo Carreño‐Tarragona, Rafael Andrés del Orbe, Gonzalo Caballero‐Navarro, Elena Magro Mazo, Ana Pardo Sanz, José Luis Zamorano Gómez, Alberto Álvarez Larrán, Valentín Garcia‐Gutierrez   +19 more
wiley   +1 more source

Targeted Superior Vena Cava Isolation Combined With Pulmonary Vein Isolation Versus Pulmonary Vein Isolation Alone Using Cryoballoon Ablation for Atrial Fibrillation

Clinical Cardiology, Volume 49, Issue 9, September 2026.
Cryoballoon‐based targeted superior vena cava isolation (SVCI) added to pulmonary vein isolation (PVI) improved 12‐month freedom from atrial tachyarrhythmia compared with PVI alone (90.9% vs. 76.4%, p = 0.037) without increasing complications, supporting systematic SVC trigger assessment in atrial fibrillation ablation. ABSTRACT Background The superior
Yanxin Han, Yangyang Bao, Yun Xie, Yue Wei, Qingzhi Luo, Tianyou Ling, Wenqi Pan, Ning Zhang, Qi Jin, Changjian Lin, Liqun Wu   +10 more
wiley   +1 more source

Comparison of CYP2C9 activity between Ethiopian and non-Ethiopian Jews: an interethnic study of (<i>S</i>)-warfarin pharmacokinetic and pharmacodynamic. [PDF]

Front Pharmacol
Wanounou M, Abu Ghosh Z, Shaul C, Mujahed W, Alamia S, Blotnick S, Bialer M, Caraco Y.   +7 more
europepmc   +1 more source

Recent Advancements in Drug Delivery Across the Blood–Brain Barrier in Amyotrophic Lateral Sclerosis (ALS)

CNS Neuroscience &Therapeutics, Volume 32, Issue 9, September 2026.
Progressive BBB/BSCB dysfunction is increasingly recognized as both a pathological feature and a therapeutic barrier in ALS. Novel delivery technologies and barrier‐restoration strategies may enhance CNS drug exposure, improve the efficacy of disease‐modifying therapies, and advance ALS treatment. ABSTRACT Background Amyotrophic lateral sclerosis (ALS)
Nitesh Sanghai, Kaitlyn Pierce, Nidhi Sharma, Sasha Leggett, Tara Chand Yadav, Pegah Masrori, Devi Atukorallaya, Senthilnathan Palaniyandi, Paul C. Marcogliese, Geoffrey K. Tranmer   +9 more
wiley   +1 more source

Left Atrial Appendage Closure Versus Oral Anticoagulation for Stroke Prevention in Non-Valvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. [PDF]

Cureus
Shetty USA, Gunaratne H, Sharma A, Rafi RI, Eusha SSA, Chaudhary S, Wei CR, Hirani S.   +7 more
europepmc   +1 more source